KBW keeps HIVE at neutral after earnings beat, flags $276 million GPU funding need

KBW kept its Market Perform rating and $4.50 price target on HIVE (NASDAQ: HIVE) on Monday after the operator posted better-than-expected EBITDA and expanded its contracted AI cloud revenue. The target implies about 67% upside from the $2.69 share price cited…



